1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0163209
DC FieldValue
dc.titleNovel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo
dc.contributor.authorNirvanappa A.C.
dc.contributor.authorMohan C.D.
dc.contributor.authorRangappa S.
dc.contributor.authorAnanda H.
dc.contributor.authorSukhorukov A.Y.
dc.contributor.authorShanmugam M.K.
dc.contributor.authorSundaram M.S.
dc.contributor.authorNayaka S.C.
dc.contributor.authorGirish K.S.
dc.contributor.authorChinnathambi A.
dc.contributor.authorZayed M.E.
dc.contributor.authorAlharbi S.A.
dc.contributor.authorSethi G.
dc.contributor.authorBasappa
dc.contributor.authorRangappa K.S.
dc.date.accessioned2018-05-30T07:10:23Z
dc.date.available2018-05-30T07:10:23Z
dc.date.issued2016
dc.identifier.citationNirvanappa A.C., Mohan C.D., Rangappa S., Ananda H., Sukhorukov A.Y., Shanmugam M.K., Sundaram M.S., Nayaka S.C., Girish K.S., Chinnathambi A., Zayed M.E., Alharbi S.A., Sethi G., Basappa, Rangappa K.S. (2016). Novel Synthetic Oxazines Target NF-κB in Colon Cancer In Vitro and Inflammatory Bowel Disease In Vivo. PLoS ONE 11 (9) : e0163209. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0163209
dc.identifier.issn19326203
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/142678
dc.publisherPublic Library of Science (PLoS)
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentPHARMACOLOGY
dc.description.doi10.1371/journal.pone.0163209
dc.description.sourcetitlePLoS ONE
dc.description.volume11
dc.description.issue9
dc.description.pagee0163209
dc.identifier.isiut000384328500029
dc.published.statePublished
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
pone.0163209.pdf2.7 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.